Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam pharmacokinetics and sedation crossover study in healthy adults
NL-OMON34288Active, not recruiting
- Sponsor
- Mediar Therapeutics
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midazolam in None and epilepsy (4 arms), sponsored by Mediar Therapeutics. Started Jan 2011; status: active, not recruiting.
02
Drugs
midazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON34288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34288.